Holocene Advisors, LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1700574 New York, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,653,453

+$206,282 QoQ

Shares Held

166,867

-7.7% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#185

of 673 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Holocene Advisors, LP holds $298,952,947 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	3,601,472	$188,717,132
2	LNTH	Lantheus Holdings, Inc.	546,961	$60,679,853
3	ELAN	Elanco Animal Health Inc	1,694,717	$41,706,985
4	TEVA	Teva Pharmaceutical Industries Ltd This page	166,867	$5,653,453
5	HIMS	Hims & Hers Health, Inc.	38,962	$1,350,812
6	UTHR	UNITED THERAPEUTICS Corp	1,559	$844,712

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,653,453	166,867	-7.7%	Shares	Sole	2026-08-14
2026-03-31	$5,447,171	180,849	-94.1%	Shares	Sole	2026-05-15
2025-06-30	$51,173,978	3,053,340	-24.1%	Shares	Sole	2025-08-14
2025-03-31	$61,797,052	4,020,628	+26.9%	Shares	Sole	2025-05-15
2024-12-31	$69,853,862	3,169,413	+43.3%	Shares	Sole	2025-02-14
2024-09-30	$39,861,735	2,212,083	-51.8%	Shares	Sole	2024-11-14
2024-06-30	$74,526,920	4,586,272	-7.6%	Shares	Sole	2024-08-14
2024-03-31	$70,020,254	4,962,456	-5.6%	Shares	Sole	2024-05-15
2023-12-31	$54,895,555	5,258,195	+2.6%	Shares	Sole	2024-02-14
2023-09-30	$52,252,284	5,122,773	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.